Abstract
Purpose of Review
To review issues regarding the practical implementation of screening strategies for masked hypertension.
Recent Findings
Masked hypertension has been associated with an increased risk of cardiovascular disease events and all-cause mortality. Recent guidelines have encouraged practitioners to use out-of-clinic monitoring to detect masked hypertension in some situations. However, it is unclear from these guidelines who should be screened or how to best measure out-of-office blood pressure. In this review, challenges to screening strategies for masked hypertension, and factors that should be considered when deciding to screen using ambulatory or home blood pressure monitoring.
Summary
Masked hypertension is an important clinical phenotype to detect. Future research is needed in order to develop optimal screening strategies, and to understand population level implications of using ambulatory or home blood pressure monitoring on blood pressure control.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Anstey DE, Pugliese D, Abdalla M, Bello NA, Givens R, Shimbo D. An update on masked hypertension. Curr Hypertens Rep. 2017;19(12):94.
Asayama K, Thijs L, Li Y, Gu YM, Hara A, Liu YP, et al. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population. Hypertension. 2014;64(5):935–42.
•• Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. This guideline addresses the detection and management of masked hypertension in Europe, with specific recommendations regarding thresholds for hypertensive range clinic blood pressure and out-of-clinic blood pressure.
•• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269–324. This guideline addresses the detection and management of masked hypertension in the U.S., with specific recommendations regarding thresholds for hypertensive range clinic blood pressure and out-of-clinic blood pressure.
Franklin SS, O’Brien E, Thijs L, Asayama K, Staessen JA. Masked hypertension: a phenomenon of measurement. Hypertension. 2015;65(1):16–20.
• Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378(16):1509–20. This study examined data from a multicenter, national cohort and investigated the association between clinic and ambulatory blood pressure measurements and all-cause and cardiovascular mortality.
Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37(4):253–390.
Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, et al. Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Can J Cardiol. 2017;33(5):557–76.
Booth JN 3rd, Muntner P, Diaz KM, et al. Evaluation of criteria to detect masked hypertension. J Clin Hypertens (Greenwich). 2016;18(11):1086–94.
Brguljan-Hitij J, Thijs L, Li Y, Hansen TW, Boggia J, Liu YP, et al. Risk stratification by ambulatory blood pressure monitoring across JNC classes of conventional blood pressure. Am J Hypertens. 2014;27(7):956–65.
Anstey DE, Booth JN 3rd, Abdalla M, et al. Predicted atherosclerotic cardiovascular disease risk and masked hypertension among Blacks in the Jackson Heart Study. Circ Cardiovasc Qual Outcomes. 2017;10(7). This study examined how cardiovascular disease risk prediction equations may be used to identify individuals with masked hypertension.
Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review. J Am Soc Hypertens. 2016;10(3):224–234 e217.
Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review. Ann Intern Med. 2015;163(9):691–700. This review describes and examines important issues related to both ambulatory blood pressure monitoring and home blood pressure monitoring.
Ostchega Y, Zhang G, Kit BK, Nwankwo T. Factors associated with home blood pressure monitoring among US adults: National Health and Nutrition Examination Survey, 2011-2014. Am J Hypertens. 2017;30(11):1126–32.
Abdalla M, Booth JN 3rd, Seals SR, et al. Masked hypertension and incident clinic hypertension among Blacks in the Jackson Heart Study. Hypertension. 2016;68(1):220–6.
Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28(10):2036–45.
Muntner P, Lewis CE, Diaz KM, Carson AP, Kim Y, Calhoun D, et al. Racial differences in abnormal ambulatory blood pressure monitoring measures: Results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Hypertens. 2015;28(5):640–8.
Abdalla M, Caughey MC, Tanner RM, et al. Associations of blood pressure dipping patterns with left ventricular mass and left ventricular hypertrophy in Blacks: The Jackson Heart Study. J Am Heart Assoc. 2017;6(4).
Cuspidi C, Facchetti R, Bombelli M, Sala C, Negri F, Grassi G, et al. Nighttime blood pressure and new-onset left ventricular hypertrophy: findings from the Pamela population. Hypertension. 2013;62(1):78–84.
Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomenico SD, Verdecchia P, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 2016;67(4):693–700.
Anstey DE, Muntner P, Bello NA, Pugliese DN, Yano Y, Kronish IM, et al. Diagnosing masked hypertension using ambulatory blood pressure monitoring, home blood pressure monitoring, or both? Hypertension. 2018;72(5):1200–7.
Kario K, Chen CH, Park S, Park CG, Hoshide S, Cheng HM, et al. Consensus document on improving hypertension management in Asian patients, Taking Into Account Asian Characteristics. Hypertension. 2018;71(3):375–82.
Funding
MA receives support through 18AMFDP34380732 from the American Heart Association.
NM receives support through NHLBI (R01 HL141609-01).
IK receives support through the Agency for Healthcare Research and Quality (R01 HS-024262).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Implementation to Increase Blood Pressure Control: What Works?
Rights and permissions
About this article
Cite this article
Anstey, D.E., Moise, N., Kronish, I. et al. Masked Hypertension: Whom and How to Screen?. Curr Hypertens Rep 21, 26 (2019). https://doi.org/10.1007/s11906-019-0931-1
Published:
DOI: https://doi.org/10.1007/s11906-019-0931-1